Rivia AG

XEMPERIA, a spin-off from the University of Fribourg, is pioneering a groundbreaking approach to blood testing that leverages the body's immune response to detect breast cancer at its earliest and most treatable stage.

Rockstone Engineering specializes in automation, digitalization, and Industry 4.0 for life sciences. We provide DCS & MES solutions, CQV, operational readiness, and project management to optimize pharma and biotech operations, ensuring efficiency, compliance, and future-proof manufacturing.

MicThera harnesses microbes to discover breakthrough therapeutics, leveraging microbial bioactive molecules -synthetically produced- to overcome therapy resistance. Our discovery platform unlocks microbial-inspired therapeutics to develop innovative treatments.